| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Minocycline in the eradication of Helicobacter pylori infection: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kai Zhou, Cai-Ling Li, Hua Zhang, Bao-Jun Suo, Yu-Xin Zhang, Xin-Lu Ren, Yu-Xin Wang, Chang-Min Mi, Ling-Ling Ma, Li-Ya Zhou, Xue-Li Tian and Zhi-Qiang Song |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82170562 |
| Beijing Natural Science Foundation |
7232199 |
| Capital’s Funds for Health Improvement and Research |
2022-2-4093 |
| Youth Incubation Fund of Peking University Third Hospital |
BYSYFY2021003 |
| Key Laboratory for Helicobacter pylori Infection and Upper Gastrointestinal Diseases in Beijing |
BZ0371 |
|
| Corresponding Author |
Zhi-Qiang Song, MD, Doctor, Doctor, Department of Gastroenterology, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. szqinputh@163.com |
| Key Words |
Helicobacter pylori; Minocycline; Eradication; Safety; Resistance |
| Core Tip |
Regarding the utilization of minocycline in the eradication therapy of Helicobacter pylori (H. pylori) infection, there is a lack of literature summarizing the potential and role of minocycline in the eradication of H. pylori infection. This is the first comprehensive account of the role, efficacy, and current state of research on minocycline in the eradication therapy of H. pylori infection by traditional meta-analysis as well as single-arm meta-analysis methods. We have summarized this minocycline in terms of bactericidal mechanism, pharmacodynamics, pharmacokinetics, drug resistance, eradication efficacy, safety and compliance. |
| Publish Date |
2024-05-05 10:12 |
| Citation |
Zhou K, Li CL, Zhang H, Suo BJ, Zhang YX, Ren XL, Wang YX, Mi CM, Ma LL, Zhou LY, Tian XL, Song ZQ. Minocycline in the eradication of Helicobacter pylori infection: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(17): 2354-2368 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i17/2354.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i17.2354 |
